M1A.459
Other secondary chronic gout, unspecified hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary chronic gout affecting the hip, classified under ICD-10 code M1A.459, is a condition characterized by persistent, long-term gout that primarily impacts the hip joint. Gout is a type of arthritis caused by the buildup of uric acid crystals in the joints. When it becomes chronic and resistant to standard treatments, it is termed secondary, indicating it has an underlying cause related to other health issues. This form of gout can lead to joint damage and significantly impact quality of life if not managed properly.
Causes & Symptoms
Clinical Causes: Chronic elevation of uric acid levels in the blood (hyperuricemia) Underlying health conditions such as kidney disease, obesity, hypertension, or metabolic syndrome Use of certain medications that increase uric acid levels, such as diuretics Diet high in purine-rich foods like red meat, shellfish, or alcohol consumption Genetic predisposition to impaired uric acid excretion or overproduction
Key Symptoms: Persistent pain in the hip joint, often worsening over time Swelling, redness, and warmth around the affected joint Limited range of motion or stiffness in the hip Formation of tophi, which are deposits of uric acid crystals under the skin near the joint Potential joint deformity if the condition progresses without treatment Joint tenderness even when not actively inflamed
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. The following are typically used: - Arthrocentesis: extraction and analysis of joint fluid to identify uric acid crystals - Blood tests: measuring serum uric acid levels - Imaging studies: X-rays, ultrasound, or dual-energy CT scans to detect joint damage or tophi - Assessment of underlying conditions that may contribute to gout, such as kidney function tests While elevated uric acid levels alone do not confirm gout, joint fluid analysis remains the gold standard for diagnosis.
Treatment Protocols: Management of secondary chronic gout includes addressing both the symptoms and the underlying causes: - **Medications:** - Uric acid-lowering agents such as allopurinol or febuxostat - Anti-inflammatory drugs like NSAIDs, colchicine, or corticosteroids for acute attacks - **Lifestyle modifications:** - Dietary changes to reduce purine intake - Maintaining a healthy weight - Increasing hydration to promote uric acid excretion - **Managing underlying conditions:** - Controlling hypertension, diabetes, or kidney disease - Reviewing and adjusting medications that may influence uric acid levels - **Monitoring:** - Regular blood tests to track uric acid levels - Periodic imaging evaluations to assess joint health Early and consistent management can help prevent joint destruction and improve joint function, enhancing overall quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M1A.459 a billable ICD-10 code?
Yes, M1A.459 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.459?
Clinical documentation must specify the nature of Other secondary chronic gout, unspecified hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference